A new generation of implantable electrodes
Therapeutic outcomes from clinical neural implants are limited by their mechanical properties. Their stiff and rigid designs present a mechanical mismatch compared to the soft and curved tissues they interface with, thereby constraining the physiological motion dynamics of the nervous system.
At Neurosoft Bioelectronics, we are addressing this issue by engineering elasticity in thin film materials to manufacture implantable electrodes that are much softer and flexible, and that can seamlessly interface with the nervous system.
Latest News
Neurosoft Bioelectronics passes Venture Kick stage 2
We are very pleased to announce that Neurosoft Bioelectronics has passed stage 2 of Venture Kick and received a second round of funding of 40 000 CHF. The Venture Kick jury has selected our project to receive the second “kick” and has chosen to support us in further...
Neurosoft arrives in second position at the >>venture>> 2020 Health & Nutrition competition
During the 2020 >>venture>> award ceremony, Neurosoft Bioelectronics was ranked 2nd in the Health & Nutrition category. We were one of the three finalists (along with Urodea and NextKidney) out of 89 initial applicants in our vertical.The >>venture>> competition...
Neurosoft Bioelectronics selected for MassChallenge Switzerland 2020 Accelerator
Neurosoft Bioelectronics was selected to participate in the MassChallenge Switzerland 2020 accelerator program. We were one of over 1’000 other startups to apply for the accelerator located in Lausanne, Switzerland. This program will allow us to engage with industry...
Supported by
